Literature DB >> 27107061

Expression of Genes with Copy Number Alterations and Survival of Patients with Pancreatic Adenocarcinoma.

David J Birnbaum1, François Bertucci2, Pascal Finetti3, José Adélaïde3, Marc Giovannini4, Olivier Turrini5, Jean Robert Delpero5, Jean Luc Raoul6, Max Chaffanet3, Vincent Moutardier7, Daniel Birnbaum3, Emilie Mamessier8.   

Abstract

BACKGROUND/AIM: Individual molecular information might improve management of pancreatic adenocarcinoma. To identify actionable genes, at the transcriptional level, we investigated candidate genes that we had previously identified using array-comparative genomic hybridization (aCGH).
MATERIALS AND METHODS: We collected 10 public gene-expression datasets, gathering a total of 524 pancreatic samples (105 normal and 419 malignant tissues). Based on our previous aCGH analysis, we searched for genes differentially expressed between normal and malignant samples and genes associated with survival.
RESULTS: Among genes amplified/gained by aCGH, 48% were overexpressed in malignant tissues. The majority of these genes were related to apoptosis, cell-cycle regulation and differentiation. Among genes located in areas of loss, 41% were underexpressed in malignant tissues; most of them were involved in ion transport, homeostasis maintenance and fatty acid metabolism. Survival analysis identified genes significantly related to shorter (n=17) or longer (n=29) survival.
CONCLUSION: Some of these genes can be further investigated as potential prognostic markers. Copyright
© 2016, International Institute of Anticancer Research (Dr. John G. Delinasios), All rights reserved.

Entities:  

Keywords:  aCGH; apoptosis; cell-cycle regulation; copy number alterations; pancreatic adenocarcinoma

Mesh:

Year:  2016        PMID: 27107061

Source DB:  PubMed          Journal:  Cancer Genomics Proteomics        ISSN: 1109-6535            Impact factor:   4.069


  3 in total

Review 1.  Transportome Malfunctions and the Hallmarks of Pancreatic Cancer.

Authors:  Qi Ling; Holger Kalthoff
Journal:  Rev Physiol Biochem Pharmacol       Date:  2021       Impact factor: 5.545

2.  A novel 20-gene prognostic score in pancreatic adenocarcinoma.

Authors:  Seçil Demirkol Canlı; Ege Dedeoğlu; Muhammad Waqas Akbar; Barış Küçükkaraduman; Murat İşbilen; Özge Şükrüoğlu Erdoğan; Seda Kılıç Erciyas; Hülya Yazıcı; Burçak Vural; Ali Osmay Güre
Journal:  PLoS One       Date:  2020-04-20       Impact factor: 3.240

3.  NOXA expression drives synthetic lethality to RUNX1 inhibition in pancreatic cancer.

Authors:  Josefina Doffo; Stefanos A Bamopoulos; Hazal Köse; Felix Orben; Chuanbing Zang; Miriam Pons; Alexander T den Dekker; Rutger W W Brouwer; Apoorva Baluapuri; Stefan Habringer; Maximillian Reichert; Anuradha Illendula; Oliver H Krämer; Markus Schick; Elmar Wolf; Wilfred F J van IJcken; Irene Esposito; Ulrich Keller; Günter Schneider; Matthias Wirth
Journal:  Proc Natl Acad Sci U S A       Date:  2022-03-01       Impact factor: 12.779

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.